FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1080940 · Received July 23, 2008

Report

Report Number
2134265-2008-02074
Event Type
Injury
Date Received
July 23, 2008
Date of Event
July 10, 2008
Report Date
July 11, 2008
Manufacturer
BOSTON SCIENTIFIC
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVAL: THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVAL; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFO FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A DRUG ELUTING STENTING TREATMENT PROCEDURE, STENT DISLODGEMENT OCCURRED. THE 75% STENOTIC LESION WAS LOCATED IN THE SEVERELY TORTUOUS (ABOUT 90 DEGREES) AND NON-CALCIFIED PROXIMAL RIGHT CORONARY ARTERY. THE PHYSICIAN FIRST PRE-DILATED THE LESION WITH A 3.5 X 15MM APEX BALLOON. THEN THE PHYSICIAN ADVANCED THE 3.50X20MM TAXUS EXPRESS2 STENT TO THE LESION AND TRIED TO CROSS THE LESION SEVERAL TIMES, BUT WAS UNABLE TO CROSS. DURING THE WITHDRAWAL OF THE STENT DELIVERY SYSTEM THE STENT DISLODGED AT THE OSTIUM OF THE CORONARY ARTERY. THE DISLODGED STENT WAS RETRIEVED FROM THE PT WITHOUT ANY INJURIES OR COMPLICATIONS. TREATMENT FOR THE LESION WAS POSTPONED TO A LATER DATE. PT CONDITION IS REPORTED AS "GOOD".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM NIQ STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC 3.50X20MM 11067634

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention